Company Monitoring Page for Roche

latest headlines for company on cafepharma

Blueprint plots return to FDA with new Ayvakit data in rare condition — and the analysts cheer
Endpoints
Tue, 09/22/20 - 10:17 pm
Tags:
Blueprint Medicines, Roche, FDA, Ayvakit
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field
Fierce Biotech
Mon, 09/21/20 - 10:28 am
Tags:
Roche, M&A, Inflazome, inflammatory disease
ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga
Fierce Biotech
Sun, 09/20/20 - 08:02 pm
Tags:
Roche, prostate cancer, ESMO, JNJ, Ipatasertib, Zytiga
ESMO: Roche's mixed results put Tecentriq's triple-negative breast cancer use into question
Fierce Pharma
Sun, 09/20/20 - 07:57 pm
Tags:
ESMO, Roche, Tecentriq, triple negative breast cancer, Merck, Keytruda
Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study
MedCity News
Sun, 09/20/20 - 07:32 pm
Tags:
Actemra, COVID-19, COVID-19 pneumonia, Roche, clinical trials
Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial
Pharmaforum
Fri, 09/18/20 - 10:42 am
Tags:
Roche, Actemra, clinical trials, ventilators, COVID-19
Roche, already prepping 2021 launch, charts big expansion plans for Lucentis eye implant
Fierce Pharma
Thu, 09/17/20 - 11:04 pm
Tags:
Roche, macular degeneration, Lucentis, eye implants, wet age-related macular degeneration
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
Mon, 09/14/20 - 10:53 am
Tags:
ESMO, immunotherapy, Big Pharma, Merck, Bristol-Meyers Squibb, cancer, Immunomedics, Roche
Sharp knives and hemophilia? No problem in Roche's new work-life miniseries
Fierce Pharma
Fri, 09/11/20 - 10:51 am
Tags:
hemophilia, Roche, pharma marketing
FDA puts Roche's Tecentriq under the lens in breast cancer after recent trial flop
Fierce Pharma
Wed, 09/9/20 - 08:05 pm
Tags:
Roche, Tecentriq, triple negative breast cancer, paclitaxel, clinical trials, FDA
Novartis, Roche fined $526M in France for alleged Lucentis marketing missteps
Fierce Pharma
Wed, 09/9/20 - 10:59 am
Tags:
Novartis, Roche, France, Lucentis, anti-competitive scheme
Big pharma spinouts grow up
EP Vantage
Tue, 09/8/20 - 10:53 am
Tags:
Big Pharma, spinoffs, Merck KGaA, Pfizer, GSK, Novartis, Roche, Sanofi, JNJ, AstraZeneca
Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe
Fierce Biotech
Thu, 09/3/20 - 10:18 am
Tags:
Roche, COVID-19, diagnostics, Europe, FDA, Emergency Use Authorization
AbbVie keeps TV ad lead in July, Roche and Pfizer follow in mildly curbed pharma TV market
Fierce Pharma
Mon, 08/24/20 - 10:18 am
Tags:
television ads, Roche, Pfizer, AbbVie, pandemic, DTC ads, COVID-19
Is valrox dead?
EP Vantage
Thu, 08/20/20 - 11:09 am
Tags:
Biomarin, hemophilia A, valrox, gene therapy, Roche, Pfizer, FDA
Turning Point touts positive pivotal NSCLC data, hints at even faster OK — but can it beat Pfizer and Roche?
Endpoints
Wed, 08/19/20 - 12:18 pm
Tags:
Turning Point Therapeutics, repotrectinib, non-small cell lung cancer, clinical trials, Pfizer, Roche
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
MedCity News
Wed, 08/19/20 - 11:13 am
Tags:
Roche, Regeneron, COVID-19, antibodies, antibody cocktail
FDA to decide on TG Therapeutics’ lymphoma drug early next year
Pharmaforum
Thu, 08/13/20 - 11:53 pm
Tags:
TG Therapeutics, FDA, lymphoma, umbralisib, Bristol-Myers Squibb, Roche
Roche pulls a tumor micro-environment drug out of the freezer, hands it to a UK upstart
Endpoints
Wed, 08/12/20 - 10:35 am
Tags:
Roche, Celleron Therapeutics, solid tumors
Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus
Endpoints
Tue, 08/11/20 - 12:31 pm
Tags:
Eisai, Roche, R&D, New Jersey

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.